The International immunosuppression & Transplant Skin Cancer Collaborative (ITSCC) is an organization of dermatologic surgeons, clinicians and researchers from multiple disciplines dedicated to advancing the care and understanding of skin cancer in organ transplant recipients.
These patients are up to 65 times more likely to develop skin cancer than people without transplants. Skin cancer is the most common cancer affecting solid organ transplant recipients, affecting up to 70 percent of patients within 20 years, and is the result of intense immunosuppressive regimens.
2019 Member Meeting
ITSCC members will come together for a scientific program during the AAD meeting in Washington DC. This highly regarded educational session starts with a brief business meeting followed by peer reviewed presentations and a Tumor Board focused on immunology.
Thursday, February 28, 2019
The National Press Club
529 14th Street NW, 13th Floor
Washington, DC, USA
View details and exhibitor information
Updated on Wednesday, October 10th, 2018